ANXA6: a key molecular player in cancer progression and drug resistance
- PMID: 37129645
- PMCID: PMC10154440
- DOI: 10.1007/s12672-023-00662-x
ANXA6: a key molecular player in cancer progression and drug resistance
Abstract
Annexin-A6 (ANXA6), a Ca2+-dependent membrane binding protein, is the largest of all conserved annexin families and highly expressed in the plasma membrane and endosomal compartments. As a multifunctional scaffold protein, ANXA6 can interact with phospholipid membranes and various signaling proteins. These properties enable ANXA6 to participate in signal transduction, cholesterol homeostasis, intracellular/extracellular membrane transport, and repair of membrane domains, etc. Many studies have demonstrated that the expression of ANXA6 is consistently altered during tumor formation and progression. ANXA6 is currently known to mediate different patterns of tumor progression in different cancer types through multiple cancer-type specific mechanisms. ANXA6 is a potentially valuable marker in the diagnosis, progression, and treatment strategy of various cancers. This review mainly summarizes recent findings on the mechanism of tumor formation, development, and drug resistance of ANXA6. The contents reviewed herein may expand researchers' understanding of ANXA6 and contribute to developing ANXA6-based diagnostic and therapeutic strategies.
Keywords: ANXA6; Drug resistance; Membrane repair; Metabolic reprogramming; Migration.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
Annexin A6-A multifunctional scaffold in cell motility.Cell Adh Migr. 2017 May 4;11(3):288-304. doi: 10.1080/19336918.2016.1268318. Epub 2017 Jan 6. Cell Adh Migr. 2017. PMID: 28060548 Free PMC article. Review.
-
Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies.Cells. 2020 Aug 7;9(8):1855. doi: 10.3390/cells9081855. Cells. 2020. PMID: 32784650 Free PMC article. Review.
-
Annexin A6-Linking Ca(2+) signaling with cholesterol transport.Biochim Biophys Acta. 2011 May;1813(5):935-47. doi: 10.1016/j.bbamcr.2010.09.015. Epub 2010 Oct 1. Biochim Biophys Acta. 2011. PMID: 20888375 Review.
-
Annexin A6 is an organizer of membrane microdomains to regulate receptor localization and signalling.IUBMB Life. 2011 Nov;63(11):1009-17. doi: 10.1002/iub.540. Epub 2011 Oct 12. IUBMB Life. 2011. PMID: 21990038 Review.
-
Evidence for annexin A6-dependent plasma membrane remodelling of lipid domains.Br J Pharmacol. 2015 Apr;172(7):1677-90. doi: 10.1111/bph.13022. Epub 2015 Jan 20. Br J Pharmacol. 2015. PMID: 25409976 Free PMC article.
Cited by
-
The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids.JCI Insight. 2024 Jan 9;9(1):e172419. doi: 10.1172/jci.insight.172419. JCI Insight. 2024. PMID: 38051586 Free PMC article.
-
The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.Int J Mol Sci. 2023 Nov 28;24(23):16854. doi: 10.3390/ijms242316854. Int J Mol Sci. 2023. PMID: 38069175 Free PMC article. Review.
-
Catalytically distinct IDH1 mutants tune phenotype severity in tumor models.bioRxiv [Preprint]. 2024 Sep 14:2024.04.22.590655. doi: 10.1101/2024.04.22.590655. bioRxiv. 2024. PMID: 38712107 Free PMC article. Preprint.
-
The role of the annexin A protein family at the maternal-fetal interface.Front Endocrinol (Lausanne). 2024 Mar 1;15:1314214. doi: 10.3389/fendo.2024.1314214. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38495790 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous